American Association for Cancer Research
Browse
21598290cd120592-sup-supp_table_2.xlsx (1.04 MB)

Supplementary Table S2 from Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers

Download (1.04 MB)
dataset
posted on 2023-04-03, 20:50 authored by Daniel Hagerstrand, Alexander Tong, Steven E. Schumacher, Nina Ilic, Rhine R. Shen, Hiu Wing Cheung, Francisca Vazquez, Yashaswi Shrestha, So Young Kim, Andrew O. Giacomelli, Joseph Rosenbluh, Anna C. Schinzel, Nicole A. Spardy, David A. Barbie, Craig H. Mermel, Barbara A. Weir, Levi A. Garraway, Pablo Tamayo, Jill P. Mesirov, Rameen Beroukhim, William C. Hahn

Supplementary Table S2 - XLSX file 1063K, Gene list derived from a gene expression based comparative marker selection between cell lines with normal or amplified levels of 3q26

History

ARTICLE ABSTRACT

3q26 is frequently amplified in several cancer types with a common amplified region containing 20 genes. To identify cancer driver genes in this region, we interrogated the function of each of these genes by loss- and gain-of-function genetic screens. Specifically, we found that TLOC1 (SEC62) was selectively required for the proliferation of cell lines with 3q26 amplification. Increased TLOC1 expression induced anchorage-independent growth, and a second 3q26 gene, SKIL (SNON), facilitated cell invasion in immortalized human mammary epithelial cells. Expression of both TLOC1 and SKIL induced subcutaneous tumor growth. Proteomic studies showed that TLOC1 binds to DDX3X, which is essential for TLOC1-induced transformation and affected protein translation. SKIL induced invasion through upregulation of SLUG (SNAI2) expression. Together, these studies identify TLOC1 and SKIL as driver genes at 3q26 and more broadly suggest that cooperating genes may be coamplified in other regions with somatic copy number gain.Significance: These studies identify TLOC1 and SKIL as driver genes in 3q26. These observations provide evidence that regions of somatic copy number gain may harbor cooperating genes of different but complementary functions. Cancer Discov; 3(9); 1044–57. ©2013 AACR.This article is highlighted in the In This Issue feature, p. 953